Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus Baptist Gallwitz Review Article 19 October 2012 Pages: 87 - 100
Antipsychotic-Induced Hyponatraemia Didier MeulendijksCyndie K. MannesseToine C. G. Egberts Review Article 19 October 2012 Pages: 101 - 114
Hyperlipidaemia in Paediatric Patients Anthony S. WierzbickiAdie Viljoen Review Article 19 October 2012 Pages: 115 - 125
Safety-Related Regulatory Actions for Orphan Drugs in the US and EU Harald E. HeemstraThijs J. GiezenHubert G. M. Leufkens Short Communication 19 October 2012 Pages: 127 - 137
Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System Steven BaileyAjay SinghMichael Blum Short Communication 19 October 2012 Pages: 139 - 146
Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinson’s Disease Jaime KulisevskyJavier Pagonabarraga Original Research Article 19 October 2012 Pages: 147 - 161
Comment on ’Prevalence, Incidence and Nature of Prescribing Errors in Hospital Inpatients: A Systematic Review’ Bryony Dean FranklinMonsey McLeodNick Barber Correspondence 19 October 2012 Pages: 163 - 165
The Authors’ Reply Penny J. LewisTim DornanDarren M. Ashcroft Correspondence 19 October 2012 Pages: 165 - 166
Drug Form and Expression of Concentration May also Lead to Prescription Errors Vaithianadan ManiDaniel W. Wheeler Correspondence 19 October 2012 Pages: 167 - 168
The Authors’ Reply Mary P. TullyDarren M. AshcroftVal Wass Correspondence 19 October 2012 Pages: 168 - 169